Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:33406400  

Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export.

Ke Wang | Wan Huang | Ruo Chen | Peng Lin | Tao Zhang | Yun-Feng Ni | Hao Li | Jiao Wu | Xiu-Xuan Sun | Jie-Jie Geng | Yu-Meng Zhu | Gang Nan | Wei Zhang | Xi Chen | Ping Zhu | Huijie Bian | Zhi-Nan Chen
Cell metabolism | 2021

CD147 is a tumor-associated glycoprotein that regulates cell metabolism. However, CD147 methylation and its subsequent role in cancer cell metabolism remain unclear. Here, we detect CD147 di-methylation in 16 non-small-cell lung cancer (NSCLC) tissues using liquid chromatography-tandem mass spectrometry. CD147 is di-methylated to CD147-K234me2 by lysine methyltransferase 5A (KMT5A). The increase in KMT5A expression boosts the levels of CD147-K234me2, further promoting the interaction between CD147 and monocarboxylate transporter 4 (MCT4), which enhances the translocation of MCT4 from the cytoplasm to the membrane. Overexpression of CD147-K234me2 and KMT5A enhances glycolysis and lactate export in NSCLC cells. Clinical analysis shows that high CD147-K234me2 expression is significantly related to cancer progression and overall survival, and has prognostic significance in individuals with NSCLC, especially for those in the early stages. Our findings indicate that CD147-K234me2 plays a critical role in cancer metabolism, and it can be a highly promising therapeutic target for NSCLC.

Pubmed ID: 33406400

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

TXNDC4 antibody (antibody)

RRID:AB_1640025

This polyclonal targets TXNDC4

View all literature mentions

GST Tag antibody (antibody)

RRID:AB_2883833

This monoclonal targets GST Tag

View all literature mentions

LDHA-Specific antibody (antibody)

RRID:AB_10646429

This polyclonal targets LDHA-Specific

View all literature mentions

Goat anti-Mouse IgG (H+L) Secondary Antibody, HRP (antibody)

RRID:AB_228307

This polyclonal secondary targets IgG (H+L)

View all literature mentions

Rabbit IgG Control Antibody, Unconjugated (antibody)

RRID:AB_1163661

This unknown targets Rabbit IgG Control

View all literature mentions

GLUT4 antibody (antibody)

RRID:AB_2882186

This monoclonal targets GLUT4

View all literature mentions

KMT5A / SETD8 / Pr-SET7 antibody (antibody)

RRID:AB_10899962

This polyclonal targets KMT5A / SETD8 / Pr-SET7 antibody

View all literature mentions

Phospho-LDHA (Tyr10) Antibody (antibody)

RRID:AB_11220238

This polyclonal targets Phospho-LDHA (Tyr10)

View all literature mentions

BSA antibody (antibody)

RRID:AB_2881592

This monoclonal targets BSA

View all literature mentions

MCT4 (D-1) (antibody)

RRID:AB_10992036

This monoclonal targets MCT4 (D-1)

View all literature mentions

GLUT1 antibody (antibody)

RRID:AB_2881673

This monoclonal targets GLUT1

View all literature mentions

GFP (B-2) (antibody)

RRID:AB_627695

This monoclonal targets GFP (B-2)

View all literature mentions

A-549 (cell line)

RRID:CVCL_0023

Cell line A-549 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions